A detailed history of Tilson Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tilson Financial Group, Inc. holds 5,985 shares of BMY stock, worth $345,214. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,985
Holding current value
$345,214
% of portfolio
0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$39.66 - $51.75 $3,767 - $4,916
95 Added 1.59%
6,080 $315,000
Q3 2024

Oct 28, 2024

BUY
$39.66 - $51.75 $237,365 - $309,723
5,985 New
5,985 $249,000
Q1 2024

Apr 25, 2024

BUY
$47.98 - $54.4 $4,126 - $4,678
86 Added 1.37%
6,344 $344,000
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $10,714 - $12,784
221 Added 3.66%
6,258 $321,000
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $349,481 - $390,775
6,037 New
6,037 $350,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tilson Financial Group, Inc. Portfolio

Follow Tilson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tilson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tilson Financial Group, Inc. with notifications on news.